Vor Biopharma Cash from Financing (TTM) Trends

Vor Biopharma Inc (VOR)

1.795 +0.04 (+2.28%) USD | NASDAQ | May 03, 16:00

1.795 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	2.938M
September 30, 2023	115.17M
June 30, 2023	119.07M
March 31, 2023	119.46M
December 31, 2022	117.14M
September 30, 2022	5.186M
June 30, 2022	1.312M

Date	Value
March 31, 2022	0.263M
December 31, 2021	232.91M
September 30, 2021	232.65M
June 30, 2021	232.98M
March 31, 2021	297.61M
December 31, 2020	82.53M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.263M

Minimum

Mar 2022

297.61M

Maximum

Mar 2021

119.94M

Average

117.14M

Median

Dec 2022

Cash from Financing (TTM) Benchmarks